Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT02541760
Eligibility Criteria:
Inclusion Criteria:
* • Children who were between 2 to 6 years old
* Definite diagnosis of OME with symptoms and examination
Exclusion Criteria:
* • Currently were using corticosteroids or prophylactic monteleukast
* Chronic pulmonary or cardiac diseases or immune deficiency
* Allergic rhinitis
* Hypersensitivity to monteleukast or corticosteroids
* Avoidance of parents to fill the written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
6 Years
Study:
NCT02541760
Study Brief:
Protocol Section:
NCT02541760